Steward Partners Investment Advisory, LLC Enlivex Therapeutics Ltd. Transaction History
Steward Partners Investment Advisory, LLC
- $10.9 Billion
- Q1 2025
A detailed history of Steward Partners Investment Advisory, LLC transactions in Enlivex Therapeutics Ltd. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 2,500 shares of ENLV stock, worth $2,550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500
Previous 2,500
-0.0%
Holding current value
$2,550
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ENLV
# of Institutions
30Shares Held
3.18MCall Options Held
44.3KPut Options Held
7.1K-
Armistice Capital, LLC New York, NY1.78MShares$1.82 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny669KShares$682,3880.0% of portfolio
-
Morgan Stanley New York, NY231KShares$235,2980.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny181KShares$184,9140.0% of portfolio
-
Jane Street Group, LLC New York, NY80.8KShares$82,3740.0% of portfolio
About Enlivex Therapeutics Ltd.
- Ticker ENLV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,403,200
- Market Cap $18.8M
- Description
- Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2...